secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cardiovascular Systems Inc (—)
CIK:        0001180145
Form:       8-K
Filed at:   2023-04-27T23:59:59+00:00
Accession:  0001104659-23-051430
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 2.01, 3.01, 3.03, 5.01, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Abbott completes acquisition of Cardiovascular Systems for $20.00 per share in cash
--------------------------------------------------------------------------------

- Each CSI share converted into $20.00 cash; aggregate consideration approx. $850M.
- Stockholders approved merger at special meeting: 34,070,064 for, 123,212 against.
- CSI will be delisted from Nasdaq and deregistered with SEC via Form 25 and Form 15.
- CSI became a wholly-owned subsidiary of Abbott; charter and bylaws amended accordingly.
- Closing occurred April 27, 2023, funded by Abbott's cash on hand.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1180145/000110465923051430/0001104659-23-051430-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1180145/000110465923051430/tm2313788d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-051430

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer